| New Developments in the Diagnosis and Management of Resistant Hypertension. | |
| | |
MedLine Citation:
|
PMID: 22257056 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Arterial hypertension is a well-known disease with a worldwide high prevalence and impaired prognosis with respect to normotensive subjects, due to increased cardiovascular mortality and morbidity. Blood pressure levels over range can be successfully controlled with adequate treatment, but more than 10% of hypertensive people have their blood pressure uncontrolled despite a therapeutic regimen of 3 or more antihypertensive drugs. These patients, named to have resistant hypertension, have a worse cardiovascular prognosis than controlled hypertensive subjects. Twenty-four hour-ambulatory blood pressure monitoring (ABPM) reveals that at least one third of these patients have indeed white-coat resistant hypertension, a rather more benign entity. In view of this evidence, performance of 24h-ABPM is mandatory and to document the occurrence of subclinical target organ damage in this population before the development of cardiovascular disease is needed. This would help the physician to more rigorously implement adequate measures to control hypertension. On the other hand, the definition itself of the disease implies that conventional pharmacological treatment is not effective enough for these patients to reach normal blood pressure values. To treat resistant hypertensives, recent reports pay attention to the need to recover traditional treatments -either non-pharmacologic such as strict sodium diet restriction or pharmacologic such as the use of aldosterone receptor blockers - or to implement those treatments that are novelties, such as renal sympathetic nervous system ablation or carotid barorreceptors stimulation. This review focuses on outlining the current evidence about the diagnostic confirmation of resistant hypertension, the need to characterize these patients through 24h-ABPM, to identify the presence of subclinical target organ damage, and to deal with not only classical but also novel treatment approaches for blood pressure control. |
| | |
Authors:
|
A Oliveras; A de la Sierra |
Related Documents
:
|
22075286 - Does previous hypertension affect outcome in acute heart failure? 2988036 - Significance of balloon pressure recording during angioplasty. an experimental study. 7990716 - Effect of hemodilution and resuscitation on tumor interstitial fluid pressure, blood fl... 21852106 - Hemodynamic effects of a right lumbar-pelvic wedge during spinal anesthesia for cesarea... 17604036 - A finite element exploration of cartilage stress near an articular incongruity during u... 22075286 - Does previous hypertension affect outcome in acute heart failure? |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-17 |
Journal Detail:
|
Title: Current medicinal chemistry Volume: - ISSN: 1875-533X ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9440157 Medline TA: Curr Med Chem Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Internal Medicine, Hospital Mutua Terrassa, Plaza Dr. Robert, 5, 08021-Terrassa, Spain. adelasierra@mutuaterrassa.es. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches.
Next Document: Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds.